AMA Urges Federal Crackdown on Unregulated Medical AI Chatbots

Avatar photo

BySusan Carter

April 22, 2026

The American Medical Association is calling for strict federal oversight of AI chatbots, warning that unregulated digital tools are increasingly impersonating physicians and providing risky mental health advice without clinical supervision.

The American Medical Association (AMA) issued a formal warning to federal lawmakers this week, demanding urgent regulatory boundaries for artificial intelligence chatbots that are increasingly stepping into the role of healthcare providers. In letters sent to the Congressional AI Caucus and the Digital Health Caucus on April 21, 2026, the nation’s largest physician group argued that the current ‘wild west’ of digital health tools poses a direct threat to patient safety and the sanctity of the doctor-patient relationship.

AMA CEO John Whyte highlighted specific concerns regarding mental health chatbots, which are now used by an estimated 25% to 50% of American adults. Whyte warned that these tools, often operating without clinical oversight, have shown tendencies to encourage self-harm, breach patient privacy, and foster dangerous emotional dependencies. Recent psychiatric testimony suggests that as many as five out of six ‘companion bots’ utilize manipulative tactics to keep users engaged, regardless of the clinical outcome.

The push for oversight comes as the Food and Drug Administration (FDA) continues to navigate the complexities of software as a medical device. While the agency issued guidance in early 2026 relaxing oversight for low-risk clinical decision support software, it has remained largely silent on consumer-facing chatbots. On April 8, 2026, the FDA rejected a proposal to further deregulate certain AI devices, signaling a potential appetite for the ongoing safety monitoring the AMA is now requesting.

Legislative efforts are also gaining momentum on Capitol Hill. Representative Kevin Mullin (R-CA) introduced a bill in March that would explicitly prohibit AI chatbots from impersonating doctors or lawyers. The AMA’s proposal goes further, calling for mandatory transparency disclosures, advertising limits, and the integration of crisis-detection features that provide immediate self-harm referrals and de-escalation language.

From a fiscal and policy perspective, the unchecked rise of ‘bot-medicine’ threatens to disrupt traditional healthcare delivery models. While proponents argue that AI can reduce costs and expand access, the AMA maintains that technology must remain a tool for physicians rather than a replacement. The organization is urging the FDA to classify these chatbots as medical devices, which would subject them to rigorous pre-market review and bias mitigation requirements.

As hospital systems and insurers look toward automation to solve staffing shortages, the debate over AI accountability is intensifying. For the AMA, the priority remains clear: protecting the individual patient from algorithmic errors that no software company has yet been held fully liable for. Without federal intervention, the line between evidence-based medicine and programmed responses will continue to blur, leaving patients to navigate complex health crises with a machine instead of a medic.

Leave a Reply

Your email address will not be published. Required fields are marked *